These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2065954)

  • 21. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
    Ali SF
    Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-donor platelet concentrates stored in synthetic medium. In vitro and in vivo studies.
    Bertolini F; Marangoni F; Loy A; Marconi M; Almini D; Rebulla P; Sirchia G
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():135-8. PubMed ID: 8013972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of pooled platelet concentrates prepared from buffy coats and stored in an additive solution after filtration.
    Koerner K; Weihe R; Sahlmen P; Zeller B; Seifried E; Cardoso M; Kubanek B
    Ann Hematol; 1995 Feb; 70(2):97-102. PubMed ID: 7880932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional characteristics of S-59 photochemically treated platelet concentrates derived from buffy coats.
    van Rhenen DJ; Vermeij J; Mayaudon V; Hind C; Lin L; Corash L
    Vox Sang; 2000; 79(4):206-14. PubMed ID: 11155071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro evaluation of a new filter for leucocyte depletion of platelet concentrate during component preparation.
    Christensen LD; Dickmeiss E
    Vox Sang; 1994; 67(3):267-71. PubMed ID: 7863626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Blood fractionation based on the extraction of the buffy-coat layer. Analysis of our results].
    Algora M; Torres P; Rodríguez MA; de la Calle C; Biurrún M; Nieto S; Ruiz M; Alonso MV
    Sangre (Barc); 1995 Apr; 40(2):91-6. PubMed ID: 7784953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
    Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
    Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Room temperature storage and cryopreservation of canine platelet concentrates.
    Allyson K; Abrams-Ogg AC; Johnstone IB
    Am J Vet Res; 1997 Nov; 58(11):1338-47. PubMed ID: 9361903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preparation of leukocyte-depleted human platelet concentrates by centrifugation and filtration of a pool of sterilely connected buffy-coats].
    Angué M; Chatelain P; Domy M; Guignier F; Richaud P
    Rev Fr Transfus Hemobiol; 1991 Jan; 34(1):9-19. PubMed ID: 2015038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel technique for preparing improved buffy coat platelet concentrates.
    Mrowiec ZR; Oleksowicz L; Dutcher JP; De Leon-Fernandez M; Lalezari P; Puszkin EG
    Blood Cells Mol Dis; 1995; 21(1):25-33. PubMed ID: 7655858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
    Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
    Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of leukocyte-poor platelet concentrates from buffy coats. I. Special inserts for centrifuge cups.
    Pietersz RN; Reesink HW; Dekker WJ; Fijen FJ
    Vox Sang; 1987; 53(4):203-7. PubMed ID: 3439099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefit of prestorage leukocyte depletion of single-donor platelet concentrates.
    Chalandon Y; Mermillod B; Beris P; Doucet A; Chapuis B; Roux-Lombard P; Dayer JM
    Vox Sang; 1999; 76(1):27-37. PubMed ID: 9933851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet concentrates in an additive solution prepared from pooled buffy coats. 1. In vitro studies.
    Eriksson L; Högman CF
    Vox Sang; 1990; 59(3):140-5. PubMed ID: 2264316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo properties of various types of platelets.
    Rebulla P
    Vox Sang; 1998; 74 Suppl 2():217-22. PubMed ID: 9704448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)].
    Hurtado C; Bonanad S; Soler MA; Mirabet V; Blasco I; Planelles MD; de Miguel A
    Sangre (Barc); 1999 Oct; 44(5):319-26. PubMed ID: 10618907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of leucocyte-poor platelet concentrates from buffy coats. IV. Clinical evaluation.
    Pietersz RN; Reesink HW; Huijgens PC; van Oers MH
    Vox Sang; 1988; 55(3):129-32. PubMed ID: 3070936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet concentrates from fresh or overnight-stored blood, an international study.
    Dijkstra-Tiekstra MJ; van der Meer PF; Cardigan R; Devine D; Prowse C; Sandgren P; de Wildt-Eggen J;
    Transfusion; 2011 Jan; 51 Suppl 1():38S-44S. PubMed ID: 21223294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evaluation of microbial contamination in platelet concentrates prepared by two different methods.
    Kocazeybek B; Arabaci U; Akdur H; Sezgiç M; Erentürk S
    Transfus Apher Sci; 2001 Oct; 25(2):107-12. PubMed ID: 11761274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags.
    Cardigan R; Sutherland J; Garwood M; Bashir S; Turner C; Smith K; Hancock V; Wiltshire M; Pergande C; Williamson LM
    Vox Sang; 2008 Feb; 94(2):103-12. PubMed ID: 18034786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.